Skip to main content
TipRanks
Go Ultimate75% OFF

CareTrust REIT (0A1C) AI Stock Analysis

1 Followers
GB:0A1C

CareTrust REIT

(LSE:0A1C)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
FFO Growth and Raised GuidanceRaised guidance and expected double-digit normalized FFO growth indicate strong near-term earnings momentum supported by the existing portfolio and completed investments. This improves visibility into recurring cash earnings and provides a durable base for continued shareholder distributions and reinvestment.
Negative Factors
Higher Debt and Leverage VisibilityThe recent increase in total debt raises exposure to refinancing costs and reduces financial flexibility if operating conditions weaken. Although annual leverage had improved, the invalid or missing-looking TTM debt-to-equity figure makes current leverage harder to assess and increases uncertainty around balance-sheet resilience.

CareTrust REIT (0A1C) vs. iShares MSCI United Kingdom ETF (EWC)

0%5%10%15%20%25%30%GB:0A1C0.00%EWC+16.25%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 9.78B
Dividend Yield
4.11%
Average Volume (3M)
―
Price to Earnings (P/E)
23.6
Beta (1Y)
―
Revenue Growth
37.38%
EPS Growth
12.15%
Country
UK
Employees
43
Sector
Real Estate
Sector Strength
65
Industry
REIT - Healthcare Facilities

CareTrust REIT Business Overview & Revenue Model

Company Description

CareTrust REIT, Inc. operates as a self-managed, publicly traded real estate investment trust. The company specializes in the ownership, acquisition, development, and leasing of various healthcare properties, including skilled nursing facilities, sen...

CareTrust REIT Earnings Call Summary

Earnings Call Date:Nov 05, 2026(Q3-2026)|% Change Since:0.00%|Next Earnings Date:Feb 11, 2027
Earnings Call SentimentPositive

The call was strongly positive. CareTrust reported 20% year-over-year per-share earnings growth, record investment activity, raised 2026 guidance, strong lease coverage, substantial liquidity, low leverage, and a large pipeline led by the strategic LNT relationship. The company also identified higher rates, cap rate compression, tax leakage, uncertain purchase-option timing, and flat share performance as challenges, but management remained confident in its ability to deliver meaningful and potentially double-digit growth.

Positive Updates

Normalized FFO and FAD Growth
Third-quarter normalized FFO increased 37% year over year to $129.2 million, while normalized FAD increased 36% to $127 million. Normalized FFO per share and normalized FAD per share were each $0.54 and $0.53, respectively, representing 20% increases over the prior-year quarter.

Negative Updates

Higher Interest Rates and Market Uncertainty
Management said rates have moved against the industry during the fall and referenced a rising-rate and higher-for-longer environment. It also said that higher rates have pressured some tenants' decisions to exercise purchase options.

Company Guidance

CareTrust raised the low end of its full year 2026 guidance and now projects normalized FFO per share of $2.08 to $2.09 and normalized FAD per share of $2.04 to $2.05, representing midpoint growth of 18.5% and 16.2%, respectively, based on a weighted average diluted share count of 240 million shares; assumptions include no new investments, loans, or dispositions beyond those made or announced year-to-date, no new debt or equity issuances beyond those made year-to-date, 2.5% inflation-based rent escalators, $147 million of loans to be repaid throughout the year, of which $111 million have been received so far to date, and no material change in the pound sterling to U.S. dollar spot exchange rate. The pipeline is just over $1.2 billion, with roughly 1/2 comprising 21 remaining LNT homes expected to close between January and September, roughly another 20% U.S. SHOP, and the balance skilled nursing, U.K. care homes, and loan activity; later next year, the company expects to begin converting LNT homes to a RIDEA structure by acquiring the opcos at a 20% yield on in-place EBITDA. Management said that, if it utilized available capacity to fund the pipeline, it could be reporting another year of double-digit normalized FFO per share growth by the end of 2027 while keeping pro forma leverage still well below the long-term target range of 4x to 5x, and it continues to underwrite SHOP investments to a low double-digit unlevered IRR, 10-year hold.

CareTrust REIT Risk Analysis

CareTrust REIT disclosed 50 risk factors in its most recent earnings report. CareTrust REIT reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

CareTrust REIT Peers Comparison

Overall Rating

UnderperformOutperform
Sector (65)

Financial Indicators

GB:0A1C against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
OHIOHI83Outperform$14.33B18.6114.32%5.73%13.90%37.56%
NHINHI77Outperform$3.07B4.3841.65%5.93%28.04%347.16%
LTCLTC75Outperform$2.37B4.3039.59%5.47%68.94%1200.88%
SBRASBRA72Outperform$5.40B73.642.55%5.82%21.20%-61.51%
Sector *65Neutral$2.17B12.193.79%4.94%3.15%1.96%
STRWSTRW55Neutral$690.66M55.8225.32%5.37%10.13%-63.21%

* Real Estate Sector Average

Performance Comparison

0%20%GB:0A1CLTCNHIOHISBRASTRWDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
GB:0A1C and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:0A1CCareTrust REIT14.120.000.00%
LTCLtc Properties41.717.8523.17%
NHINational Health Investors62.43-11.97-16.09%
OHIOmega Healthcare Investors47.094.9611.77%
SBRASabra Healthcare Reit20.623.1317.90%
STRWStrawberry Fields REIT Inc12.281.1410.26%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.